Composer review (2026)

Composer is the easiest way we've tested to go from "I have a strategy idea" to real-money automated execution. That convenience, not backtesting rigor, is the product. You describe a rules-based strategy in plain English or drag together a logic tree, backtest it instantly against bundled adjusted daily data for free, then deploy it live with one click because Composer is the brokerage (Composer Securities LLC, executing through Alpaca and clearing through Apex). Since June 2026 it operates as "Composer by SoFi," which resolves the startup-longevity question that used to hang over it.

As a backtesting engine, though, it is the shallowest tool in our ranking's mid-field. Simulations run exclusively on daily adjusted closing prices, with a default 1 basis point slippage assumption. Composer's own docs concede that those closes "don't represent real quotes from any point during the trading day." There is no intraday data, no walk-forward analysis and no optimization framework, while the community leaderboard of eye-watering hypothetical CAGRs is an overfitting machine. Live executions happen in a trade window using real-time quotes, so divergence from the backtest is structural; users report exactly that on low-volume ETFs.

Score it for what it is. At 6.2 overall, this is a superb automation product wrapped around a basic backtester. Retail investors running monthly ETF rotations will love it; anyone validating strategies seriously should test elsewhere (QuantConnect, VectorBT) and only then consider Composer as an execution venue.

Composer is a no-code automated trading platform and SEC-registered broker-dealer, acquired by SoFi in June 2026 and rebranded "Composer by SoFi." Strategies, called symphonies, are built in a visual logic-tree editor or generated by an AI assistant from natural-language prompts, then backtested and deployed to live automated trading inside the same app. Unlike TradingView or TrendSpider, Composer is not a charting or signals layer that hands orders to your broker: it is the brokerage. Composer Securities LLC executes through Alpaca Securities with clearing at Apex Clearing, and supports taxable accounts plus Roth, Traditional, and Rollover IRAs.

The platform covers US stocks and ETFs, crypto in eligible states (via Alpaca Crypto custody), and, since December 2025, options selling in the form of covered calls and cash-secured puts. A community library of thousands of shared symphonies lets you copy, edit, and redeploy other users' strategies. An API and MCP integration (the October 2025 "Trade With AI" release) let LLMs build, backtest, and execute strategies programmatically, which makes Composer one of the more genuinely AI-native products in this comparison. Access is web and iOS. There is no desktop software.

Composer's backtester is instant, unlimited and free. It is also methodologically thin. Per the official docs, simulations for stocks and ETFs use daily adjusted closing prices, adjusted for splits and dividends, and Composer explicitly warns these "don't represent real quotes from any point during the trading day." Strategy conditions can be evaluated daily, weekly, or monthly; there is no minute, hourly, or tick simulation, and no way to model intraday entries.

On the cost side it is better than many retail tools. Backtests deduct SEC fees ($27.80 per $1M sold), FINRA CAT and TAF fees, and apply a default slippage of 1 basis point, adjustable to stress different conditions. The Trading Pass fee itself can optionally be included.

The structural accuracy gap sits between simulation and execution. Live symphonies make decisions during a daily trading window using real-time quotes, so a strategy can legitimately take different trades than its backtest suggested. Composer documents this, and Trustpilot reviewers note visible slippage on low-volume ETFs. There is no walk-forward testing, out-of-sample splitting, or Monte Carlo analysis, and the community's hypothetical-return leaderboards make curve-fitting the path of least resistance. Treat backtests here as sanity checks, not validation.

Data is Composer's quiet strength and its hard ceiling at once. Everything is bundled: split- and dividend-adjusted daily history for US stocks and ETFs, plus crypto price history, at zero cost even on the free tier. There are no exchange fees, no data subscriptions and nothing to configure, which is a real advantage over AmiBroker or NinjaTrader, where sourcing clean adjusted data is its own project.

Now the ceiling. Resolution is daily closes, full stop. There is no intraday data at any tier, and Composer does not publish an official statement of historical depth. In practice, backtest start dates are bounded by each ticker's or ETF's inception, and we could not verify a documented survivorship-bias policy for delisted symbols, which matters for stock-picking strategies. You cannot import your own data, alternative datasets, or fundamentals beyond what the editor's built-in indicators expose (price, moving averages, RSI, drawdown, volatility, and similar).

For the platform's core use case, tactical allocation across liquid ETFs on daily-or-slower schedules, the bundled data is clean and entirely adequate. For anything requiring intraday granularity, custom datasets, or delisting-aware universes, it is disqualifying.

Composer's pricing is simple and, for backtesters, unusually generous. The free tier includes unlimited strategy building and backtesting, AI strategy generation, API access, and strategy sharing. You pay only when you want live automated execution.

The Trading Pass costs $40/month billed monthly, or $384/year (≈$32/month, a 20% discount), and unlocks fully automated live trading, portfolio metrics, strategy analytics, and retirement accounts. A 14-day free trial applies. Note that the pricing page leads with the $32/mo annual figure; the $40 monthly rate is confirmed in the help center. FINRA/SEC regulatory fees are passed through on sells, fractions of a cent per share in practice. A Business tier with API access, real-time data management, and mark-to-market accounting is custom-priced.

The referral program can eliminate the fee entirely: each referred friend who buys a Trading Pass grants a stacking 25% lifetime discount, so four referrals make it free. Against alternatives, $384/year compares to TradingView Premium (~$600/yr) plus a broker integration, or QuantConnect's ~$60/mo live node. That is competitive if automation is what you're buying, expensive if you only backtest, which is free anyway.

Composer fits a specific profile: US-based retail investors who want systematic, hands-off strategies (momentum ETF rotation, risk-on/risk-off switches, leveraged-ETF hedging, tactical asset allocation) running on autopilot at daily or slower cadence, in taxable accounts or IRAs, without writing a line of code. For that user it is arguably the best product on the market, and the free tier is an excellent no-risk sandbox for learning systematic-investing concepts.

It is the wrong tool for intraday traders (one daily trade window, daily data), for anyone outside the US (Composer Securities is US-only), for coders who want custom logic, custom data, or their own broker (closed ecosystem, no export path), and for anyone whose priority is statistically rigorous validation (no walk-forward, no out-of-sample tooling, daily closes only).

If you're evaluating alternatives: TradingView or TrendSpider for chart-driven strategy testing with broker flexibility; QuantConnect for institutional-grade multi-asset backtesting with code; Trade Ideas if AI-generated equity signals rather than automation is the draw. There is also a defensible hybrid workflow. Validate a strategy properly on QuantConnect or VectorBT, then use Composer purely as the cheapest no-ops execution layer for the daily-rebalance version.